Jeremy Luban and his colleagues at Columbia University in New York, and Heinrich Göttlinger's team at Harvard Medical School in Boston, studied the interaction of HIV with cyclophilin A in laboratory cultures. (newscientist.com)
The resulting cDNA (double line) has two different fates, which are determined by the sequence of the capsid and its interaction with Cyclophilin A proteins (red drops). (sciencedaily.com)
If cyclophilin A could be somehow switched off, HIV could be controlled in the body. (newscientist.com)